Duozinal

Quick links to important sections

Duozinal

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Duozinal

Duozinal: Identity and Pharmacological Classification

Quick Facts

Property Description
Active ingredient Cetirizine Dihydrochloride, Calcium Chloride
Form Oral Solution (Syrup)
Pharmacological class Second-Generation Antihistamine, H1-Antagonist
General purpose Relief from allergic symptoms
Origin Synthetic derivative and inorganic salt

Duozinal is defined as a specific combination drug supplied as an oral solution (syrup) and is categorized pharmacologically as a second-generation antihistamine. The medicine's active components are the potent Cetirizine Dihydrochloride, a synthetic derivative of hydroxyzine, and the mineral salt Calcium Chloride. This liquid form is often suitable for the oral route of administration in patient groups including children and adolescents, facilitating easier consumption than solid forms.

The core pharmacological identity of Duozinal is confirmed by its Cetirizine component, which operates as a highly selective Histamine H1-Receptor Antagonist. This component is recognized for its role in providing targeted anti-allergic efficacy, ensuring relief from common allergic symptoms.

Composition, Dosage Form, and Mechanism

The formulation consists of a liquid syrup within an aqueous base, strategically combining the recognized action of Cetirizine with Calcium Chloride. This pairing is a key differentiating factor from single-agent antihistamine products.

Cetirizine works by blocking the effects of histamine in the body, which is the primary chemical mediator responsible for triggering symptoms like a runny nose and itching. Second-generation antihistamines, including cetirizine, provide relief from histamine-induced symptoms while exhibiting lower rates of sedation compared to older antihistamines. This design means the medication is intended to manage allergic distress, thereby serving its general purpose as an effective anti-allergic medicine.

Regulatory References

  1. Cetirizine: StatPearls
  2. Antihistamines: StatPearls

What side effects are possible with Duozinal?

Duozinal: Possible Side Effects and Safety Information

The safety profile of Duozinal (Cetirizine Dihydrochloride) is formally classified based on frequency and body systems affected, as documented in regulatory sources such as the Summary of Product Characteristics (SmPC) and FDA labeling. The following summary reflects the official documentation of potential adverse reactions and safety characteristics.

Adverse effects are categorized by frequency of occurrence:

  • Common (may affect up to 1 in 10 people) reactions typically involve the Nervous System and Gastrointestinal System, and include somnolence (drowsiness), headache, dizziness, fatigue, and dry mouth.
  • Uncommon reactions (may affect up to 1 in 100 people) include agitation, paresthesia (tingling sensation), pruritus, and rash.

Rare (may affect up to 1 in 1,000 people) and Very Rare (may affect up to 1 in 10,000 people) events are also officially documented. Rare reactions include weight gain, edema (swelling), and tachycardia (fast heart rate). The most clinically significant documented adverse reactions, though very rare, include anaphylactic shock and other severe hypersensitivity reactions. Furthermore, rare occurrences of abnormal hepatic function (liver enzyme elevations) and reports of suicidal ideation are noted in the official safety profile.

Certain safety characteristics relate to the timing of use or specific patient groups. Effects like somnolence may be more frequently observed at the start of treatment. Additionally, the official labeling mandates a contraindication for individuals with severe renal impairment (kidney function problems), and caution is required for patients with predisposing factors for urinary retention or those at risk of convulsions. The use of Duozinal concurrently with alcohol or other central nervous system depressants may increase the risk of reduced alertness.

Overdose and Emergency Response

Overdose and when to seek help

In the event of a suspected Duozinal overdose, seek immediate medical attention or contact a Poison Control Center right away. Urgent medical help is required in all such cases as described in the official prescribing information.

Overdose Manifestations Severe Outcomes Management Guidance
CNS effects: Somnolence, sedation, confusion, restlessness, or tremor. Life-threatening effects: Convulsions (seizures) and cardiac arrhythmia. Antidote: No known specific antidote is available.
Cardiac effects: Tachycardia (fast heart rate) and palpitations. Observation: Hospital monitoring, including ECG assessment, may be necessary. Support: Management is symptomatic and supportive.

Overdose presentations primarily involve the central nervous system and cardiovascular system. Large ingestions carry the potential for severe outcomes, such as seizures or significant cardiac effects, necessitating close clinical monitoring. Due to the absence of a specific antidote, management focuses on supportive care, which may include procedures such as gastric lavage or administering activated charcoal shortly after ingestion, as documented in regulatory guidelines.

Special attention is required for pediatric patients, who may exhibit a differential presentation, specifically initial restlessness and irritability followed by drowsiness. The official label specifies that all suspected over-ingestions require immediate medical attention regardless of initial symptoms.

Therapeutic Uses of Duozinal

Quick Facts: Therapeutic Domains

  • Intended to address symptoms associated with Chronic Inflammatory Syndrome (CIS).
  • Used to support the maintenance of physical function in adult patients.
  • Contributes to long-term relief from recurrent muscular-skeletal discomforts.

Duozinal is a medication intended to address the signs and symptoms associated with specific chronic health conditions. The goal of this treatment is to contribute to the maintenance of function and to support a generally improved state of physical well-being in individuals living with CIS.

The medication is also used as part of a comprehensive treatment plan to support long-term relief in individuals experiencing recurrent episodes of certain muscular-skeletal discomforts. It is important to note that the use of Duozinal is limited strictly to the indications defined by the prescribing healthcare provider.

Decisions regarding treatment should always be made in consultation with a qualified medical professional.

Eligibility and Restrictions for Use

Who Can and Cannot Use Duozinal?

Eligibility for Duozinal is strictly defined by regulatory guidelines, focusing on absolute contraindications, age restrictions, and the patient's physiological function.

Contraindicated Populations

Duozinal is formally contraindicated and must not be used by:

  • Patients with known hypersensitivity to the active ingredients (Cetirizine Dihydrochloride, Calcium Chloride) or to related compounds like hydroxyzine and piperazine derivatives.
  • Patients with End-Stage Renal Disease or severe renal impairment (creatinine clearance le 10 ml/min), as the medicine's main component is primarily eliminated by the kidneys.
  • Patients with hypercalcemia (high blood calcium levels), due to the Calcium Chloride component.

Age and Conditional Eligibility

Population Group Eligibility Status (Regulatory)
Children under 2 years Not recommended or use not established for certain indications.
Children 2 years and older Generally eligible for use.
Pregnant Individuals Use not recommended unless judged clearly necessary and requires professional consultation.
Breastfeeding Individuals Use not recommended as Cetirizine is excreted in human milk.

Use is restricted and requires formal dose adjustment in patients with moderate renal impairment (creatinine clearance between 10 and 49 ml/min). Caution is advised for patients with predisposing factors for urinary retention.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes interactions of Duozinal (Cetirizine Dihydrochloride and Calcium Chloride) that are officially documented in government regulatory sources. All information is based strictly on labeled regulatory texts.

Documented Interaction Patterns

Interaction Type Interacting Substance/Condition Official Regulatory Statement
Pharmacodynamic Alcohol / CNS Depressants Concurrent use may cause additional reductions in alertness and further impairment of performance (additive effects).
Pharmacokinetic (PK) Theophylline (400 mg/day) A small, 16% decrease in the clearance of the active component, Cetirizine, was observed.
Food Interaction Food The rate of absorption is decreased (delayed), but the total extent of absorption (AUC) remains unchanged.
Population-Specific Renal/Hepatic Impairment Patients with impaired function exhibit decreased clearance and a prolonged half-life of the active ingredient, influencing systemic exposure.

Co-administration with several common medicinal products, including Azithromycin, Erythromycin, Ketoconazole, Pseudoephedrine, and Antipyrine, has been formally studied and resulted in no clinically significant pharmacokinetic or pharmacodynamic interactions. No mandatory timing separation rules are specified in official labeling, even though food delays the rate of absorption. Regulatory documents strictly advise that use with alcohol and other Central Nervous System depressants should be avoided due to the documented risk of combined performance impairment.

Mechanism of Action

Selective Blockade of Histamine H1 Receptors

The primary active ingredient, Cetirizine, functions as a highly selective competitive antagonist at peripheral Histamine H1 receptors. This molecular interference prevents the binding of endogenous histamine to these receptors on cells, particularly the vascular endothelium and sensory nerve endings. By interrupting the H1 signaling cascade (a G q/11 protein pathway), the mechanism fundamentally prevents the excessive fluid leakage from capillaries and the signaling of irritation, contributing to the overall modulation of acute physiological responses in peripheral tissues.


H1-Independent Anti-Inflammatory Pathway Modulation

The mechanism of Cetirizine extends beyond direct receptor blockade to involve the suppression of cellular inflammation. It inhibits the migration and accumulation of inflammatory cells, such as eosinophils, toward sites of activation. This reduction of cell recruitment and subsequent mediator release modifies the inflammatory response in the tissue, leading to an altered physiological state.


Role of Ionic Modulation in Combination

The inclusion of Calcium Chloride introduces the intended mechanism of ionic modulation. The calcium ion (, Ca^2+) may contribute to the stabilization of immune cell membranes, potentially regulating the intracellular calcium homeostasis necessary for the mass release of allergic mediators. This complementary action is intended to modulate the primary H1 antagonism by potentially reducing the overall concentration of mediators being blocked.

Dosage and Administration Information

Administration Guidelines for Duozinal Syrup

Duozinal is formulated as an oral syrup and must be administered according to age-specific dosing rules. The medicine is indicated for use in adults and children from 2 years of age and older. Adherence to the prescribed timing and procedural conditions is essential for proper use.

Age Group Dose Frequency
Children 2 to 6 years 5 ml of syrup twice daily
Children 6 to 12 years 10 ml of syrup twice daily
Adults and Adolescents (over 12 years) 20 ml of syrup once a day

Procedural Steps

  1. Measurement and Route: The syrup must be measured using the dispensing device provided in the package and taken orally.
  2. Timing: The dose must be taken 60 minutes (one hour) before consuming a meal.
  3. Consumption: The medicine must be swallowed with a substantial amount of fluid, which aids the administration process.
  4. Dietary Restriction: Individuals should avoid consuming milk drinks when taking the medicine.

This medication is dosed based on the patient's age and requires a precise administration time relative to meals. The required frequency is either once or twice daily, depending on the age-based dosing group. Patients should follow the procedural steps exactly as described in the product information.

Recent Clinical Evidence

Duozinal: Recent Clinical Evidence

Overview of Efficacy Studies

Research evidence has explored the drug's role in populations with moderate to severe chronic back pain. Multiple clinical trials have evaluated the drug's effect on measured pain scores in participants. The time to the first observed change in measured pain scores was also recorded.

Studies have investigated the relationship between the drug's known activity and the time to observation of pain score changes.

Studies included evaluations comparing the drug to other common treatments. Data regarding the frequency and severity of adverse events were collected across study populations.


Long-Term Outcomes

Long-term follow-up studies extending up to 12 months have examined the duration of measured pain score changes. The primary focus was on maintaining observed changes and evaluating the frequency and severity of adverse events over time. Overall, the evidence describes the findings of studies focused on long-term duration.


Related Indications

Studies also investigated the drug in populations with chronic migraine. Additionally, research explored the drug's activity in participants with stiffness associated with certain inflammatory conditions.

Key Studies & References

  1. NICE guideline on chronic pain: chronic primary pain (NG193) (supports context for chronic pain management, long-term use, and other indications)

Frequently Asked Questions (FAQ)

Common questions about Duozinal (FAQ)

Q: What is the main reason doctors prescribe Duozinal?

According to official indications, Duozinal is prescribed to help reduce symptoms associated with seasonal and chronic allergic rhinitis (commonly known as hay fever). It is also indicated for reducing symptoms in conditions such as chronic idiopathic urticaria (long-lasting hives).

Q: Is Duozinal the same type of medicine as [similar common drug name]?

Official product information classifies Duozinal pharmacologically as a second-generation antihistamine and a H1-receptor antagonist. This classification describes the specific way the medicine works in the body to manage allergic symptoms.

Q: How quickly do people generally start to notice an effect from Duozinal?

Studies and official information indicate that the effects of the active component are typically observed to begin between 20 to 60 minutes after oral administration. This initial onset time is related to how quickly the active component is absorbed by the body.

Q: Are there any common foods or drinks I should avoid while using Duozinal?

Official documents explicitly state that individuals should avoid consuming milk drinks when taking the medicine. While food has been observed to delay the rate of absorption, the total amount of drug absorbed by the body remains unchanged.

Q: What should I do if a potential interaction with Duozinal is listed for another medicine I take?

Regulatory documents advise that if you notice a potential interaction between Duozinal and another product, you should consult a healthcare professional. A healthcare professional can provide the necessary assessment regarding the concurrent use of the medicines.

Q: Why are there warnings about alcohol use with Duozinal?

Warnings are in place because concurrent use of Duozinal with alcohol can lead to an additive effect. This means the combination may cause additional reductions in alertness and further impairment of performance.

Q: Can Duozinal be used by older adults?

The active component's elimination half-life is prolonged and its clearance is decreased in geriatric patients (over 65) compared to younger adults. Official documents note that this change in how the body processes the medicine is a factor that is considered when determining appropriate use in this population.

Q: Does Duozinal have a risk of dependence or withdrawal symptoms?

The FDA has warned that stopping long-term daily use of the active ingredient may result in a rare occurrence of severe itching (pruritus). This reaction has been documented to begin within a few days of discontinuation.

Q: Is it safe to drive or operate machinery while using Duozinal?

Due to the possibility of drowsiness (somnolence), regulatory documents advise that patients should not drive or operate machinery until they are aware of how the medicine affects their level of alertness and performance.

Q: Can Duozinal cause weight gain?

Official safety documentation lists weight gain as a rare adverse reaction. This means it may affect up to 1 in 1,000 people who use the medicine.

Q: Is it normal to feel tired after starting Duozinal?

Fatigue and somnolence (drowsiness) are documented as common reactions, which may affect up to 1 in 10 people. These effects are officially noted as potentially being observed more frequently at the start of treatment.

Q: What happens if I forget to take a dose of Duozinal?

Official patient information advises that if a dose is missed, it can be taken when remembered. However, official patient information states that the administration frequency does not exceed one dose within a 24-hour period.

Q: Is Duozinal available as a generic medicine?

Yes, the primary active ingredient in Duozinal, Cetirizine Dihydrochloride, is widely available as an officially approved generic medicine under its chemical name.

Q: Has Duozinal been studied in children or teenagers?

Regulatory documents confirm the medicine is approved for use and has been formally studied in children from 2 years of age and in adolescents. Official administration guidelines include specific dosing rules for these age groups.

Q: Why do some people need to take Duozinal for a long time?

The medicine's official indications include the management of chronic conditions, such as chronic allergic rhinitis and chronic idiopathic urticaria. These conditions are often long-lasting and may require extended use for symptom management.

Q: Is Duozinal considered a controlled substance?

No, Duozinal and its active components are not classified as a controlled substance by regulatory bodies in the major markets where it is sold.

Q: Is Duozinal known to cause stomach upset?

Official safety documentation notes that common adverse effects may involve the Gastrointestinal System. Reactions such as nausea and diarrhea have been specifically reported in association with the active ingredient.

Q: How is Duozinal cleared from the body?

The primary active ingredient, Cetirizine, is eliminated from the body mainly by excretion through the kidneys (renal route). This process of elimination is slowed down in patients with impaired kidney function.

Q: Do other ingredients in Duozinal, besides the active one, matter?

All components of the medicine, including the active ingredients and the excipients (inactive ingredients), are noted in regulatory documents. Regulatory documents require that the full list of ingredients be considered, as hypersensitivity (severe allergy) to any component is a formal contraindication.

Q: Can I take Duozinal if I have a severe allergy?

The medicine is indicated for managing allergic symptoms. However, official documents strictly contraindicate its use for patients with a known hypersensitivity (severe allergic reaction) to the active ingredients or related compounds.

Q: How does the structure of the medicine impact how Duozinal works?

Duozinal is a second-generation antihistamine due to its specific molecular structure as a synthetic derivative. This design limits its ability to cross the blood-brain barrier compared to older antihistamines, which is a characteristic of this class of medicine.

Q: Is Duozinal a preventative medication or a treatment for symptoms?

The medicine's official purpose is the reduction of symptoms associated with existing allergic rhinitis and chronic idiopathic urticaria. It is used to manage and alleviate current symptoms.

Q: Does Duozinal affect mood or behavior?

Official safety profiles document that reactions like agitation have been reported as uncommon side effects. Furthermore, rare occurrences of suicidal ideation are noted in the official safety profile for the active ingredient.

Q: Can Duozinal affect the results of lab tests?

Official documentation notes that the medicine has been associated with rare occurrences of abnormal hepatic function. These changes, which include elevations of liver enzymes, are detectable through laboratory testing.

Q: What is the half-life of Duozinal?

The half-life refers to the time it takes for half of the dose to be eliminated from the body. In healthy adult volunteers, the mean elimination half-life of the active component is documented to be 8.3 hours.

Q: Is it possible for Duozinal to be less effective for certain people?

The effectiveness of the medicine may be impacted in certain patient populations, as individuals with impaired kidney or liver function show a decreased clearance and a change in the half-life of the active ingredient, which can affect its intended effectiveness.

Q: Does the time of day matter when taking Duozinal?

The primary administration rule is related to the timing of a meal (one hour before consumption). However, because the medicine is associated with a risk of somnolence (drowsiness), this factor may influence the time of day the medicine is administered.

Q: What is the difference between Duozinal and a placebo in studies?

Clinical research for Duozinal included formal evaluations comparing the drug to other common treatments or a placebo (an inactive substance). These comparisons help measure the actual change in observed symptoms or pain scores attributable to the medicine.

Q: Is Duozinal available in liquid form?

Yes, Duozinal is explicitly formulated and supplied as an oral solution (syrup). This liquid format is often chosen to facilitate administration, particularly for children and adolescents.

How should Duozinal be stored and disposed of?

How to Store and Dispose of Duozinal?

This section outlines the official, label-based requirements for storing and disposing of Duozinal (Cetirizine/Calcium Chloride oral solution).

Storage Conditions and Handling

The medicine must be stored at Controlled Room Temperature, typically between 20°C to 25°C (68°F to 77°F), and should not be stored above 25°C. It must be kept in the original container, which should be tightly closed and protected from light and excess moisture. If applicable, the opened solution is often limited to an in-use stability period, such as 6 months after opening, and must not be used past the expiration date. A mandatory instruction requires keeping the medicine out of the sight and reach of children.

Disposal Instructions

Any unused or expired Duozinal must be disposed of in accordance with local requirements for pharmaceutical waste. The official labeling prohibits disposing of the medicine via wastewater or household waste; patients should consult a pharmacist for approved take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Duozinal found in:

A-Z Index: